Helianthus Lifesciences Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Newglim MV 2mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Newglim MV 2mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Newglim MV 2mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Newglim MV 2mg/500mg/0.2mg Tablet.
Newglim MV 2mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Newglim MV 2mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Newglim MV 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Newglim MV 2mg/500mg/0.2mg Tablet is a combination medication containing Glimepiride, Metformin, and Voglibose, used to treat type 2 diabetes mellitus (DM). It works by improving blood glucose levels in adults when combined with appropriate lifestyle modifications like diet and exercise. Glimepiride increases insulin release from the pancreas, metformin reduces glucose production in the liver and improves insulin sensitivity, and Voglibose inhibits alpha-glucosidase activity, lowering postprandial (after meals) glucose levels. This combination is not indicated for treating type 1 DM.
Potential side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash, and respiratory tract infections. These effects may occur more often if you miss meals, take alcohol, exercise excessively, or utilize other antidiabetic medications.
Newglim MV 2mg/500mg/0.2mg Tablet should not be used in individuals with known hypersensitivity to any component or excipient of this medication. Additionally, it is contraindicated for patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
No, consuming alcohol with Newglim MV 2mg/500mg/0.2mg Tablet is not recommended as it can exacerbate hypoglycemia and potentially lead to lactic acidosis.
Yes, taking Newglim MV 2mg/500mg/0.2mg Tablet may lead to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, a rapid heart rate, and feelings of anxiety or shakiness. It's more likely to occur with missed meals, alcohol consumption, excessive exercise, or the use of other antidiabetic medications simultaneously. Regular monitoring of blood glucose levels is essential.
Store this medication in its original package with a tight seal, as indicated on the label or packaging instructions. Do not use expired medicine. Dispose of unused medication responsibly. Ensure it's inaccessible to children, pets, and other individuals.